BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6453301)

  • 21. Ubiquitin is a component of neurofibrillary tangles in a variety of neurodegenerative diseases.
    Lennox G; Lowe J; Morrell K; Landon M; Mayer RJ
    Neurosci Lett; 1988 Nov; 94(1-2):211-7. PubMed ID: 2853854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulovacuolar degeneration in the ageing brain and in dementia.
    Ball MJ; Lo P
    J Neuropathol Exp Neurol; 1977 May; 36(3):474-87. PubMed ID: 870622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
    Joachim CL; Morris JH; Kosik KS; Selkoe DJ
    Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of granulovacuolar degeneration in hippocampal neurones to aging and to dementia in normal-pressure hydrocephalics.
    Ball MJ; Vis CL
    J Gerontol; 1978 Nov; 33(6):815-24. PubMed ID: 744856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alzheimer's disease: an olfactory connection?
    Mann DM; Tucker CM; Yates PO
    Mech Ageing Dev; 1988 Jan; 42(1):1-15. PubMed ID: 2964546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease in Down's syndrome. A review.
    Karlinsky H
    J Am Geriatr Soc; 1986 Oct; 34(10):728-34. PubMed ID: 2944942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology.
    Sadowski M; Wisniewski HM; Tarnawski M; Kozlowski PB; Lach B; Wegiel J
    Acta Neuropathol; 1999 Feb; 97(2):156-64. PubMed ID: 9928826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laminar distribution of neuritic plaques in normal aging, Alzheimer's disease and Down's syndrome.
    Rafalowska J; Barcikowska M; Wen GY; Wisniewski HM
    Acta Neuropathol; 1988; 77(1):21-5. PubMed ID: 2977047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurofibrillary tangles of paired helical filaments.
    Wiśniewski HM; Narang HK; Terry RD
    J Neurol Sci; 1976 Feb; 27(2):173-81. PubMed ID: 129541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia.
    Aylward EH; Li Q; Honeycutt NA; Warren AC; Pulsifer MB; Barta PE; Chan MD; Smith PD; Jerram M; Pearlson GD
    Am J Psychiatry; 1999 Apr; 156(4):564-8. PubMed ID: 10200735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathological studies on senile plaques in brains of patients with Down's syndrome.
    Fukuoka Y; Fujita T; Ito H
    Kobe J Med Sci; 1990 Dec; 36(5-6):153-71. PubMed ID: 1708000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease.
    Doebler JA; Markesbery WR; Anthony A; Rhoads RE
    J Neuropathol Exp Neurol; 1987 Jan; 46(1):28-39. PubMed ID: 2432192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence activated cell sorting (FACS) as a separation method for neurofibrillary tangles in Alzheimer's disease.
    Hussey S; Yates CM; Fink G
    J Neurosci Methods; 1986 Mar; 16(1):1-8. PubMed ID: 2422499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.
    Hanger DP; Brion JP; Gallo JM; Cairns NJ; Luthert PJ; Anderton BH
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):99-104. PubMed ID: 1826835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome.
    Mann DM; Esiri MM
    J Neurol Sci; 1989 Feb; 89(2-3):169-79. PubMed ID: 2522541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.
    Teipel SJ; Schapiro MB; Alexander GE; Krasuski JS; Horwitz B; Hoehne C; Möller HJ; Rapoport SI; Hampel H
    Am J Psychiatry; 2003 Oct; 160(10):1870-8. PubMed ID: 14514503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The second layer neurones of the entorhinal cortex and the perforant path in physiological ageing and Alzheimer's disease.
    Moryś J; Sadowski M; Barcikowska M; Maciejewska B; Narkiewicz O
    Acta Neurobiol Exp (Wars); 1994; 54(1):47-53. PubMed ID: 8023713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia.
    Casanova MF; Carosella NW; Gold JM; Kleinman JE; Weinberger DR; Powers RE
    Psychiatry Res; 1993 Oct; 49(1):41-62. PubMed ID: 8140181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological features of Pick's and atypical Alzheimer's disease in Down's syndrome.
    Pogacar S; Rubio A
    Acta Neuropathol; 1982; 58(4):249-54. PubMed ID: 6297225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.